Implication of low dose sacubitril/valsartan

被引:0
|
作者
Imamura, Teruhiko [1 ]
机构
[1] Univ Toyama, Dept Internal Med 2, 2630 Sugitani, Toyama 9300194, Japan
关键词
D O I
10.1002/clc.23561
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:289 / 289
页数:1
相关论文
共 50 条
  • [1] Re: Implication of low-dose sacubitril/valsartan
    Pandey, Amitabh C.
    Heywood, James Thomas
    CLINICAL CARDIOLOGY, 2021, 44 (03) : 290 - 290
  • [2] Transforming pediatric heart failure: Efficacy of low-dose sacubitril/valsartan
    Zha, Hui
    Zhai, Xuejia
    Wang, Lin
    Yang, Quancheng
    Guo, Qing
    Chen, Yanyu
    Liu, Jie
    Peng, Hua
    CURRENT PROBLEMS IN CARDIOLOGY, 2025, 50 (01)
  • [3] Predictors of sacubitril/valsartan high dose tolerability in HFrEF
    Visco, V. Valeria
    Radano, I.
    Campanile, A.
    Masarone, D.
    Pacileo, G.
    Correale, M.
    Mazzeo, P.
    Dattilo, G.
    Mercurio, V.
    Tocchetti, C. G.
    Di Pietro, P.
    Carrizzo, A.
    Galasso, G.
    Vecchione, C.
    Ciccarelli, M.
    EUROPEAN JOURNAL OF HEART FAILURE, 2022, 24 : 116 - 116
  • [4] Clinical evidence of initiating a very low dose of sacubitril/valsartan: a prospective observational analysis
    Kim, Hyoeun
    Oh, Jaewon
    Lee, Sanghyup
    Ha, Jaehyung
    Yoon, Minjae
    Chun, Kyeong-hyeon
    Lee, Chan Joo
    Park, Sungha
    Lee, Sang-Hak
    Kang, Seok-Min
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [5] Clinical evidence of initiating a very low dose of sacubitril/valsartan: a prospective observational analysis
    Hyoeun Kim
    Jaewon Oh
    Sanghyup Lee
    Jaehyung Ha
    Minjae Yoon
    Kyeong-hyeon Chun
    Chan Joo Lee
    Sungha Park
    Sang-Hak Lee
    Seok-Min Kang
    Scientific Reports, 11
  • [6] Predictors of maximal dose titration of Sacubitril-valsartan
    Rodrigues, T. E. Graca
    Agostinho, J. R.
    Pereira, S. Couto
    Silverio-Antonio, P.
    Brito, J.
    Da Silva, P. Alves
    Silva, B. Valente
    Cunha, N.
    Garcia, B.
    Rigueira, J.
    Lousada, N.
    Silva, D.
    Pinto, F. J.
    Brito, D.
    EUROPEAN JOURNAL OF HEART FAILURE, 2021, 23 : 136 - 136
  • [7] Sacubitril/valsartan
    不详
    AUSTRALIAN PRESCRIBER, 2016, 39 (06) : 226 - 227
  • [8] Prolonged First-Dose Hypotension Induced by Sacubitril/Valsartan
    Hsiao, Fu-Chih
    Chu, Pao-Hsien
    ACTA CARDIOLOGICA SINICA, 2018, 34 (01) : 96 - 98
  • [9] Determinants of maximal dose titration of sacubitril/valsartan in clinical practice
    Martens, Pieter
    Verluyten, Lina
    Van de Broek, Heleen
    Somers, Frauke
    Dauw, Jeroen
    Dupont, Matthias
    Mullens, Wilfried
    ACTA CARDIOLOGICA, 2021, 76 (01) : 20 - 29
  • [10] Differences in patient characteristics and cardiovascular events between low dose and medium-high dose of Sacubitril-Valsartan
    Seller Moya, J. S. M.
    Nunez Piles, C. N. P.
    Morillas Climent, H. M. C.
    Vicedo Lopez, A. V. D.
    Galcera Jornet, E. M. J.
    Alania Torres, E. A. T.
    Larumbe Rodriguez, L. R. A.
    Valle Munoz, A. V. M.
    EUROPEAN JOURNAL OF HEART FAILURE, 2018, 20 : 443 - 443